Providing a centralised Hub for the innovation and application of state-of-the-art Genome Editing technologies
|
The Pre-Clinical Genome Editing core are passionate about understanding how cutting edge molecular tools can be exploited and applied to cancer research. Using CRISPR, and other technologies, we aim to make disease models that better reflect true clinical disease, and conversely, use the technology on patient-derived cells to eliminate disease.
|
Life in a post-genomic era
|
McGovern Institute for Brain Research at MIT
|
We have entered into a post-genomic era, where the goal is to functionally interrogate the vast catalogue of human annotated genetic variation. To this end, there is enormous demand for tools that enable the probing of the underlying function of genetic variation in human disease.
This is where we operate. |
News and Upcoming Talks/Events...
26th-27th Jun - Fireside chat with Dr Steve Rees (VP Discovery Biology, AstraZeneca):
'CRISPR gene editing and what's beyond' @ Health Horizons Conference, Cambridge
26th-27th Jun - Fireside chat with Dr Steve Rees (VP Discovery Biology, AstraZeneca):
'CRISPR gene editing and what's beyond' @ Health Horizons Conference, Cambridge
|
|
|
|